-
1 Comment
Avanos Medical, Inc is currently in a long term downtrend where the price is trading 13.8% below its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.9.
Avanos Medical, Inc's total revenue sank by 2.5% to $185M since the same quarter in the previous year.
Its net income has dropped by 673.8% to $-47M since the same quarter in the previous year.
Finally, its free cash flow grew by 63.6% to $-4M since the same quarter in the previous year.
Based on the above factors, Avanos Medical, Inc gets an overall score of 2/5.
Exchange | F |
---|---|
CurrencyCode | EUR |
ISIN | US05350V1061 |
Sector | Healthcare |
Industry | Medical Devices |
Market Cap | 502M |
---|---|
PE Ratio | None |
Target Price | 43 |
Beta | 1.15 |
Dividend Yield | None |
Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; OrthogenRx knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 8HH.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025